News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Aspirin a viable treatment for serious blood clots


5 November, 2012

Aspirin a viable treatment for serious blood clots, study shows

Low-dose aspirin is a cheap and effective way to prevent potentially deadly blood clots in the leg or the lungs in patients who have had a previous blood clot a new study shows.

The study, conducted by the National Health and Medical Research Council’s Clinical Trials Centre at the University of Sydney, and a team of international investigators, is published today in The New England Journal of Medicine.

The study has found that people who have suffered blood clots in the veins of the leg (deep vein thrombosis or DVT) or the lungs (pulmonary embolism or PE) are less likely to suffer a recurrence of the serious blood clots or a cardiac event if they take low-dose aspirin. These conditions affect approximately 1 in 1000 people in Australia each year.

“The results of this study suggest the simple, inexpensive treatment of low-dose aspirin could prevent thousands of patients from experiencing recurrent clots each year and may make substantial healthcare savings in Australia and worldwide,” Professor John Simes, Director of the NHMRC Clinical Trials Centre at the University of Sydney and chair of the study said.

“These results suggest that aspirin prevents about one third of recurrent blood clot events. For every 1000 patients treated for one year, aspirin can be expected to prevent about 20 to 30 episodes of recurrent major thrombotic events at the cost of about 3 significant bleeding episodes.”

Operating since 2003, the ASPIRE study completed recruitment of 822 participants from five countries including Australia, New Zealand, Singapore, India and Argentina. All the participants had previously suffered a DVT or PE that occurred for no particular reason, called ‘unprovoked VTE’ (venous thromboembolism).

They had completed on average six months of anti-coagulant treatment, generally with warfarin. They were randomly allocated to receive either low dose enteric coated aspirin or a matching placebo. On average participants were followed for three years.

Dr Tim Brighton, from Prince of Wales Hospital and principal investigator of the study, explained:

“Many patients discontinue warfarin therapy after six or twelve months of treatment due to the inconvenience of regular blood tests and the increased risks of serious bleeding [putting them at high risk of recurring thrombosis].”

“Aspirin reduces the risk of important blood clotting event including recurrent VTE, myocardial infarction, stroke, or cardiovascular death. We now have clear evidence that aspirin is of benefit for patients who are unable or do not wish to continue warfarin in the long term.”

The study results are consistent with the findings of an Italian study, called WARFASA, which a showed a significant benefit with aspirin as reported in the The New England Journal of Medicine earlier this year.

When combined, the results of the two trials show clear and consistent evidence that aspirin prevents recurrent blood clots and this is likely to be adopted into future international practice.

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Howard Davis: Orson Welles' Masterpiece - 'Chimes At Midnight'

Never widely distributed in the US, but Welles' own personal favorite and hugely influential on directors as diverse as Kenneth Branagh and Mel Gibson, a restored 50th anniversary print has now reached the New Zealand Film Festival. More>>

Off To Leeds: Wellington’s Local Naked Girl Spreads Her Wings

Wellington born, bred and based live artist Virginia Kennard, self confessed “local naked girl”, has earned a place on the MA in Performance programme at Leeds Beckett University and flies away in 2 months time. More>>

Free Diving: William Trubridge Breaks World Record

With just a single breath, New Zealand free diver William Trubridge has successfully broken his own unassisted free dive world record of 101 metres. More>>

ALSO:

RLWC 2017 Draw: New Zealand Set For A Festival Of Rugby League

New Zealand Rugby League fans will have the chance to see the Kiwis in action against the best in the Pacific region for the Rugby League World Cup 2017, as announced today at the Official Tournament Draw. More>>

ALSO:

Non-Pokemon News: Magical Park A Safer Augmented Reality For Younger Audiences

Since May, Wellington City Council has been trialling a new app, Magical Park, in collaboration with the game’s New Zealand developer Geo AR Games, in parks around the city. Magical Park uses GPS technology to get users moving around the park to play within a set boundary. More>>

'Erroneous': Pokemon App Makers On Huge Privacy Flaw

We recently discovered that the Pokémon Go account creation process on iOS erroneously requests full access permission for the user's Google account... More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news